市場調查報告書
商品編碼
422727

穿戴式心臟去顫器市場:症狀(周產期心肌病,先天性心臟病,遺傳性心律不整),終端用戶,地區別預測

Wearable Cardioverter Defibrillator Market: By Medical Condition (Peripartum Cardiomyopathy, Congenital Heart Disease, Inherited Arrhythmias); By End User (Hospitals, Home Care, Cardiology Clinics) & By Region-Forecast 2019-2024

出版日期: | 出版商: IndustryARC | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球穿戴式心臟去顫器市場相關調查,彙整市場趨勢與策略性分析,不同症狀,各終端用戶,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 穿戴式心臟去顫器市場:概要

第2章 摘要整理

第3章 市場環境

  • 市場佔有率分析
  • 競爭分析
  • 產品基準
  • 終端用戶分析
  • 前五名公司的財務分析

第4章 市場力量

  • 促進要素
  • 阻礙要素
  • 機會
  • 課題
  • 波特五力分析

第5章 策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品/市場生命週期分析
  • 供給者和經銷商

第6章 不同症狀

  • 周產期心肌病
  • 先天性心臟病
  • 遺傳性心律不整

第7章 各終端用戶

  • 醫院
  • 居家照護
  • 心臟病診所

第8章 各地區市場

  • 歐洲
  • 亞太地區
  • 北美
  • 其他

第9章 市場熵

  • 擴大
  • 技術發展
  • 合併·收購,合資企業
  • 供給 - 契約

第10章 企業簡介

第11章 附錄

目錄

Wearable cardioverter defibrillator (WCD) is a medical device worn by cardiac patients who are at risk for sudden cardiac arrest (SCA). A wearable cardioverter defibrillator allows their physician time to assess their long-term arrhythmic risk and make appropriate plans for preventing sudden cardiac arrest resulting in a fatality. Globally, an increasing number of people with cardiac diseases and technological advancement in cardiology are expected to remain the key growth drivers for the wearable cardioverter defibrillator during the period of study.

Geographically, North America dominated the wearable cardioverter defibrillator market driven by world class healthcare infrastructure with a technologically advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for the wearable cardioverter defibrillator market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the wearable cardioverter defibrillator market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the wearable cardioverter defibrillator market.

This report segments the wearable cardioverter defibrillator market on the basis of medical condition, end-user and regional market as follows:

Wearable cardioverter defibrillator market research report is classified on the basis of medical condition. Some of the major medical conditions covered in this report are as follows: Peripartum Cardiomyopathy, Congenital Heart Disease, Inherited Arrhythmias

Wearable cardioverter defibrillator market research report is classified on the basis of end-user. Some of the major end-users covered in this report are as follows: Hospitals, Home Care, Cardiology Clinics

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the wearable cardioverter defibrillator market. Some of the major companies' profiles in detail are as follows:

ZOLL Medical Corporation (A Subsidiary of Asahi Kasei Corporation)

Access Cardio Systems

BIOTRONIC SE & Co. KG

Boston Scientific Corporation

Cardiac Science Corporation

Table of Contents

1. Wearable cardioverter defibrillator Market - Overview

2. Executive Summary

3. Wearable cardioverter defibrillator Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Wearable cardioverter defibrillator Market- Forces

  • 4.1. Drivers
    • 4.1.1. Technological advancement in cardiology
    • 4.1.2. Increasing population with cardiac diseases
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Wearable cardioverter defibrillator Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Wearable cardioverter defibrillator Market, By Medical Condition

  • 6.1. Peripartum Cardiomyopathy
  • 6.2. Congenital Heart Disease
  • 6.3. Inherited Arrhythmias

7. Wearable cardioverter defibrillator Market, By End-User

  • 7.1. Hospitals
  • 7.2. Home Care
  • 7.3. Cardiology Clinics

8. Wearable cardioverter defibrillator Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. Wearable cardioverter defibrillator Market - Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. ZOLL Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
  • 10.2. Access Cardio Systems
  • 10.3. BIOTRONIC SE & Co. KG
  • 10.4. Boston Scientific Corporation
  • 10.5. Cardiac Science Corporation
  • 10.6. Defibtech LLC
  • 10.7. GE Healthcare
  • 10.8. HeartSine Technologies
  • 10.9. Medtronic Inc
  • 10.10. Nihon Kohden corporation
  • 10.11. Phillips Healthcare

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.6. Disclaimer